{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:22:19Z","timestamp":1783095739341,"version":"3.54.6"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PNRR-MR1\\u20132022\\u201312376430"],"award-info":[{"award-number":["PNRR-MR1\\u20132022\\u201312376430"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpba.2026.117574","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:50:55Z","timestamp":1779205855000},"page":"117574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MicroLC-HRMS selective quantification of a biotherapeutic fusion protein in plasma and cerebrospinal fluid of patients with Lafora disease using a linker-containing signature peptide"],"prefix":"10.1016","volume":"279","author":[{"given":"Erika","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Caravelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Muccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cancellerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tappat\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Minardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Carelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Vignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Michelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bisulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Fiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117574_bib1","article-title":"Biopharmaceutical analysis \u2014 current analytical challenges, limitations, and perspectives","author":"Cunha","year":"2025","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2026.117574_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/17576180.2024.2418250","article-title":"Perspective on LC-MS(\/MS) for biotherapeutic and biomarker proteins in research and regulated Bioanalysis: a consolidation of more than a decade of experience across the European Bioanalysis Forum community (Part 1: \u201cThe What\u201d)","volume":"17","author":"Wilson","year":"2025","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2026.117574_bib3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/14789450.2018.1469982","article-title":"The role of mass spectrometry in the characterization of biologic protein products","volume":"15","author":"Rathore","year":"2018","journal-title":"Expert Rev. Proteom."},{"key":"10.1016\/j.jpba.2026.117574_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1021\/acsmeasuresciau.3c00068","article-title":"Comprehensive Overview of Bottom-Up Proteomics Using Mass Spectrometry","volume":"4","author":"Jiang","year":"2024","journal-title":"ACS Meas. Sci. Au"},{"key":"10.1016\/j.jpba.2026.117574_bib5","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1021\/acs.analchem.2c05071","article-title":"Mass spectrometry-based charge heterogeneity characterization of therapeutic mAbs with imaged capillary isoelectric focusing and ion-exchange chromatography as separation techniques","volume":"95","author":"Wu","year":"2023","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2026.117574_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/s12014-023-09424-x","article-title":"Mass spectrometry-based proteomics as an emerging tool in clinical laboratories","volume":"20","author":"Birhanu","year":"2023","journal-title":"Clin. Proteom."},{"key":"10.1016\/j.jpba.2026.117574_bib7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.molmed.2019.08.005","article-title":"Antibody-Mediated Enzyme Therapeutics and Applications in Glycogen Storage Diseases","volume":"25","author":"Zhou","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jpba.2026.117574_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00446","article-title":"Neurological glycogen storage diseases and emerging therapeutics","volume":"21","author":"Colpaert","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jpba.2026.117574_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-01989-w","article-title":"Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis","volume":"16","author":"Pondrelli","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jpba.2026.117574_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41582-018-0057-0","article-title":"Lafora disease \u2014 from pathogenesis to treatment strategies","volume":"14","author":"Nitschke","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jpba.2026.117574_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145875","article-title":"ENT2 facilitates brain endothelial cell penetration and blood-brain barrier transport by a tumor-targeting anti-DNA autoantibody","volume":"6","author":"Rattray","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpba.2026.117574_bib12","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.jpba.2026.117574_bib13","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1007\/s12035-024-04015-9","article-title":"Receptor-Assisted Nanotherapeutics for Overcoming the Blood\u2013Brain Barrier","volume":"61","author":"Mhaske","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jpba.2026.117574_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2026.117574_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114949","article-title":"Intrathecal delivery of macromolecules: clinical status and emerging technologies","volume":"199","author":"Ajeeb","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpba.2026.117574_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ph17081070","article-title":"Advances in intrathecal nanoparticle delivery: targeting the blood\u2013cerebrospinal fluid barrier for enhanced CNS drug delivery","volume":"17","author":"Madadi","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jpba.2026.117574_bib17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2022.08.051","article-title":"Recent advances in drug delivery and targeting to the brain","volume":"350","author":"Sethi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2026.117574_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-085062","article-title":"VAL-1221 for the treatment of patients with Lafora disease: study protocol for a single-arm, open-label clinical trial","volume":"14","author":"Muccioli","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.jpba.2026.117574_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/PDR.0b013e3181b24e94","article-title":"Early treatment with alglucosidase alfa prolongs long-term survival of infants with Pompe disease","volume":"66","author":"Kishnani","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jpba.2026.117574_bib20","unstructured":"Committee for Medicinal Products for Human Use ICH guideline M10 on bioanalytical method validation and study sample analysis Step5, 2022. \u3008www.ema.europa.eu\/contact\u3009."},{"key":"10.1016\/j.jpba.2026.117574_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2025.128018","article-title":"Quantitative dried blood spot microsampling for therapeutic drug monitoring of antiseizure medications by design of experiment and UHPLC-MS\/MS","volume":"293","author":"Cancellerini","year":"2025","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2026.117574_bib22","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: Homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpba.2026.117574_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115542","article-title":"Liquid chromatography - tandem mass spectrometry method for determination of natalizumab in serum and cerebrospinal fluid of patients with multiple sclerosis","volume":"234","author":"Matlak","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117574_bib24","article-title":"New therapeutic strategies for Lafora disease: Evaluation of the safety, efficacy, pharmacokinetics and metabolomic profile of intravenous VAL-1221 treatment","author":"Muccioli","year":"2025","journal-title":"Neurotherapeutics"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526002426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526002426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:49:25Z","timestamp":1783093765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526002426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"alternative-id":["S0731708526002426"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117574","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroLC-HRMS selective quantification of a biotherapeutic fusion protein in plasma and cerebrospinal fluid of patients with Lafora disease using a linker-containing signature peptide","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117574"}}